Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Lukas

Showing results (111-120 of 120) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 120 results.
Human Brain Mapping|March 19, 2026
Brain Age Estimation on T2-FLAIR Scans for Application to Multiple SclerosisJordan Colman, Giuseppe Pontillo, Olivia Goodkin, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 14, 2018
Association of smoking but not HLA-DRB1*15:01, APOE or body mass index with brain atrophy in early multiple sclerosisChristiane Graetz, Adriane Gröger, Felix Luessi, et al.
Neurology|December 12, 2024
Association of the Cervical Canal Area With Disability and Progression in People With Multiple SclerosisNeus Mongay-Ochoa, Deborah Pareto, Manel Alberich, et al.
Cell|March 12, 2020
Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory MechanismAlexander Duscha, Barbara Gisevius, Sarah Hirschberg, et al.
Brain : a Journal of Neurology|December 14, 2022
Clinical and MRI measures to identify non-acute MOG-antibody disease in adultsRosa Cortese, Marco Battaglini, Ferran Prados, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 30, 2020
Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severityPatrick Ostkamp, Anke Salmen, Béatrice Pignolet, et al.
Annals of Neurology|May 23, 2024
Grey Matter Atrophy and its Relationship with White Matter Lesions in Patients with Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder, and Multiple SclerosisRosa Cortese, Marco Battaglini, Ferran Prados, et al.
Neurology|September 4, 2025
Deep Learning Modeling to Differentiate Multiple Sclerosis From MOG Antibody-Associated DiseaseRosa Cortese, Francesco Sforazzini, Giordano Gentile, et al.
Clinical Neuroradiology|August 18, 2025
Middle Meningeal Artery Embolization for the Treatment of Chronic Subdural Hematomas-a German Nationwide Multi-center Study On 718 EmbolizationsDominik F Vollherbst, Ansgar Berlis, Mahmoud Zaki, et al.
Neurology|November 4, 2024
Disentangling Neurodegeneration From Aging in Multiple Sclerosis Using Deep Learning: The Brain-Predicted Disease Duration GapGiuseppe Pontillo, Ferran Prados, Jordan Colman, et al.
Pageof 12

Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
Human Brain Mapping|March 19, 2026
Brain Age Estimation on T2-FLAIR Scans for Application to Multiple SclerosisJordan Colman, Giuseppe Pontillo, Olivia Goodkin, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 14, 2018
Association of smoking but not HLA-DRB1*15:01, APOE or body mass index with brain atrophy in early multiple sclerosisChristiane Graetz, Adriane Gröger, Felix Luessi, et al.
Neurology|December 12, 2024
Association of the Cervical Canal Area With Disability and Progression in People With Multiple SclerosisNeus Mongay-Ochoa, Deborah Pareto, Manel Alberich, et al.
Cell|March 12, 2020
Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory MechanismAlexander Duscha, Barbara Gisevius, Sarah Hirschberg, et al.
Brain : a Journal of Neurology|December 14, 2022
Clinical and MRI measures to identify non-acute MOG-antibody disease in adultsRosa Cortese, Marco Battaglini, Ferran Prados, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 30, 2020
Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severityPatrick Ostkamp, Anke Salmen, Béatrice Pignolet, et al.
Annals of Neurology|May 23, 2024
Grey Matter Atrophy and its Relationship with White Matter Lesions in Patients with Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder, and Multiple SclerosisRosa Cortese, Marco Battaglini, Ferran Prados, et al.
Neurology|September 4, 2025
Deep Learning Modeling to Differentiate Multiple Sclerosis From MOG Antibody-Associated DiseaseRosa Cortese, Francesco Sforazzini, Giordano Gentile, et al.
Clinical Neuroradiology|August 18, 2025
Middle Meningeal Artery Embolization for the Treatment of Chronic Subdural Hematomas-a German Nationwide Multi-center Study On 718 EmbolizationsDominik F Vollherbst, Ansgar Berlis, Mahmoud Zaki, et al.
Neurology|November 4, 2024
Disentangling Neurodegeneration From Aging in Multiple Sclerosis Using Deep Learning: The Brain-Predicted Disease Duration GapGiuseppe Pontillo, Ferran Prados, Jordan Colman, et al.
Pageof 12